http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101895418-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5f41889212134f724ee94357d02f4b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
filingDate 2017-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ffd429eb505ceb5069e820469d444a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c8c130cb79d066bc2778d62be4feb09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a239f7a7f09953882e4d942caf997335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea8e24a2015133f9668fd9577bc7223
publicationDate 2018-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101895418-B1
titleOfInvention Composition for improving anticancer efficacy of sorafenib containing emodin
abstract The present invention provides a composition for enhancing cancer therapeutic effect of sorafenib comprising emodin. The composition of the present invention significantly inhibited cancer cell growth inhibition compared to the case where each of emodine and sorafenib was administered alone and the use of sorafenib was reduced to a lower concentration than that of the conventional treatment, It can be further improved to overcome the anticancer drug resistance.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230075172-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102163524-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200041484-A
priorityDate 2017-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050020950-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100623436-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100131474-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430895435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552268
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID284363
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID34199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID284363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477623
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID34199

Total number of triples: 41.